当前位置: 首页 SCI期刊 SCIE期刊 JCRQ4 期刊介绍(非官网)
Contemporary Clinical Trials Communications

Contemporary Clinical Trials CommunicationsSCIE

国际简称:Cont Clin Trial Comm  参考译名:当代临床试验通讯

  • CiteScore分区

    Q2

  • JCR分区

    Q4

基本信息:
ISSN:2451-8654
是否OA:开放
是否预警:否
出版信息:
出版地区:United States
出版商:Elsevier
出版语言:English
研究方向:Pharmacology, Toxicology and Pharmaceutics-Pharmacology
评价信息:
影响因子:1.4
CiteScore指数:2.7
SJR指数:0.64
SNIP指数:0.66
发文数据:
Gold OA文章占比:95.19%
研究类文章占比:97.04%
年发文量:169
英文简介 期刊介绍 CiteScore数据 JCR分区 常见问题

英文简介Contemporary Clinical Trials Communications期刊介绍

Contemporary Clinical Trials Communications is an international, peer-reviewed open access journal dedicated to the field of clinical trials. This journal aims to provide a high-quality communication platform for the design, implementation, analysis, and reporting of clinical trials, in order to promote the development of the fields of medicine and biological sciences. The main goal of the magazine is to publish original research, review articles, case reports, newsletters, conference reports, and other types of articles, covering various stages of clinical trials, including trial design, data collection, statistical analysis, result interpretation, and policy formulation. In addition, the magazine also focuses on ethical issues, patient safety, data management, and regulatory policies in clinical trials. Through high-quality research articles and providing a professional communication platform, this journal is committed to promoting the development of the fields of medicine and biological sciences, providing support for the design, implementation, analysis, and reporting of clinical trials.

期刊简介Contemporary Clinical Trials Communications期刊介绍

《Contemporary Clinical Trials Communications》该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

  • 预计审稿时间: 20 Weeks
  • SCIE
  • 非预警

Cite Score数据(2024年最新版)Contemporary Clinical Trials Communications Cite Score数据

  • CiteScore:2.7
  • SJR:0.636
  • SNIP:0.657
学科类别 分区 排名 百分位
大类:Medicine 小类:General Medicine Q2 199 / 636

68%

大类:Medicine 小类:Pharmacology Q3 217 / 313

30%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

JCR分区Contemporary Clinical Trials Communications JCR分区

2023-2024 年最新版
按JIF指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL ESCI Q4 144 / 189

24.1%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL ESCI Q4 146 / 189

23.02%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

投稿常见问题